Technical Analysis for PAR - Paradigm Biopharmaceuticals Ltd

Grade Last Price % Change Price Change
C 0.255 4.08% 0.010
PAR closed up 6.52 percent on Tuesday, November 19, 2024, on 1.11 times normal volume. It was able to find support at its 50 day moving average.
Earnings due: Nov 28
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 4.08%
50 DMA Support Bullish 4.08%
180 Bullish Setup Bullish Swing Setup 4.08%
Pocket Pivot Bullish Swing Setup 4.08%
Gapped Up Strength 4.08%
Stochastic Sell Signal Bearish 10.87%
Gapped Up Strength 10.87%
Overbought Stochastic Strength 10.87%
Upper Bollinger Band Touch Strength 10.87%
Bearish Engulfing Bearish 6.25%

   Recent Intraday Alerts

Alert Time
Bullish 180 Entry about 1 hour ago
Rose Above Previous Day's High about 1 hour ago
Rose Above Upper Bollinger Band about 1 hour ago
Up 2% about 1 hour ago
Up 1% about 1 hour ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Paradigm Biopharmaceuticals Limited is a biopharmaceutical company focused on repurposing the drug pentosan polysulfate sodium (PPS) for the treatment of inflammation. The Company is engaged in researching and developing therapeutic products for human use. The Company is a drug repurposing company, which seeks to find new uses for old drugs. The Company has commenced the open labelled Phase II clinical trial, investigating the role of the drug PPS in treating traumatic Bone Marrow Lesions. The Company's Rhinosul has properties consisting of both histamine stabilizing and anti-inflammatory properties. The Company focuses on repurposing PPS under ZILOSUL name, as a treatment for bone marrow edema (BME) lesions following traumatic injury.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Drugs Pharmaceuticals Clinical Trial Biopharmaceutical Medical Specialties Pharmaceutical Industry Therapeutic Product Therapeutic Products Medication Organ Systems Inflammation Osteochondritis Dissecans

Is PAR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.48
52 Week Low 0.165
Average Volume 1,272,519
200-Day Moving Average 0.270
50-Day Moving Average 0.219
20-Day Moving Average 0.220
10-Day Moving Average 0.231
Average True Range 0.018
RSI (14) 59.84
ADX 22.26
+DI 28.960
-DI 20.607
Chandelier Exit (Long, 3 ATRs) 0.210
Chandelier Exit (Short, 3 ATRs) 0.250
Upper Bollinger Bands 0.248
Lower Bollinger Band 0.192
Percent B (%b) 0.95
BandWidth 25.660
MACD Line 0.006
MACD Signal Line 0.004
MACD Histogram 0.0029
Fundamentals Value
Market Cap 55.86 Million
Num Shares 228 Million
EPS -0.11
Price-to-Earnings (P/E) Ratio -2.25
Price-to-Sales 0.00
Price-to-Book 6.20
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.290
Resistance 3 (R3) 0.285 0.265 0.283
Resistance 2 (R2) 0.265 0.254 0.268 0.280
Resistance 1 (R1) 0.255 0.246 0.260 0.260 0.277
Pivot Point 0.235 0.235 0.238 0.238 0.235
Support 1 (S1) 0.225 0.224 0.230 0.230 0.213
Support 2 (S2) 0.205 0.216 0.208 0.210
Support 3 (S3) 0.195 0.205 0.208
Support 4 (S4) 0.200